Testing Laboratories

Accounting for New Mexico Cannabis Testing Laboratories

A CCD-licensed testing laboratory sells analysis, not cannabis, and that changes the financial picture from top to bottom. Instead of inventory costing, the operating questions are instrument utilization, sample throughput and how quickly the lab can turn results around for producers and manufacturers across the state waiting on a BioTrack release.

Cannabis manufacturing and extraction facility with stainless steel processing equipment behind clean-room glass

Financial challenges specific to this license type

  • Heavy instrument capital

    Mass spectrometers and chromatography equipment carry significant acquisition and service-contract cost, which makes depreciation schedules and financing structure central to the lab's financial model.

  • Cost per sample by panel

    Potency, pesticide, microbial and heavy-metal panels each have different cost structures. Profitability tracks cost per sample by panel type and instrument utilization rate, not aggregate revenue.

  • Revenue recognition timing

    Prepaid testing packages, rush-fee premiums and retest obligations all affect when revenue is actually earned, and getting the cutoff wrong distorts monthly margin.

  • An uncertain 280E position

    Whether a lab's activity constitutes trafficking under 280E depends on its specific licensing and handling of samples, and that analysis should be documented rather than assumed favorable in either direction.

How we work with testing laboratories

  • Cost-per-sample and cost-per-panel reporting with instrument utilization tracking
  • Depreciation, financing and service-contract planning for lab equipment
  • Service revenue recognition and deferred revenue schedules for prepaid packages
  • Documented review of the laboratory's federal tax position

280E Considerations for New Mexico Testing Laboratories

A CCD-licensed testing laboratory sells analytical services, and that reframes the entire tax conversation away from inventory costing and toward capital intensity, instrument utilization and sample throughput. Whether a laboratory's specific licensing and handling of samples brings any part of its activity within 280E's reach depends on the facts, and that determination should be documented in advance rather than assumed to favor either position.

  • Core economics: instrument depreciation, cost per sample, throughput per analyst
  • Revenue is earned as testing is performed, not when payment is received
  • The 280E position should be documented based on the lab's actual licensing and handling

Cost Accounting, Inventory and BioTrack for a Testing Lab

Mass spectrometry and chromatography equipment represents a large fixed investment, and a depreciation and maintenance-contract schedule tied to actual usage keeps the cost model realistic. Cost per sample should be tracked by test panel — potency, pesticide, microbial, heavy metal — because each panel has a distinct cost structure and blending them into one average sample cost hides where the lab is actually making or losing money.

Revenue recognition needs particular attention where the lab offers prepaid testing packages, rush-fee premiums or retest guarantees. Revenue is earned as each test is completed, not when the client pays or when the package is purchased, and a deferred revenue schedule keeps that timing straight.

Sample intake and result release both generate BioTrack events tied to the producer's or manufacturer's package, and the lab's internal sample log should reconcile to those events so results and billing stay aligned with actual compliance activity.

Tax Planning and Recommended Services

Planning for a laboratory centers on equipment financing and depreciation strategy, throughput-driven pricing, and a documented review of the 280E question specific to the lab's own facts. Because labs serve producers and manufacturers across the entire state — from Farmington and Roswell to Las Cruces — turnaround time and capacity planning are also financial decisions with real revenue consequences.

We build the accounting system first and let the tax return follow it. If you operate a licensed New Mexico testing laboratory, a diagnostic review will quantify what your current treatment is costing you before any engagement begins.

Services most relevant to this operator profile

Questions

Testing Laboratories accounting questions

Consultation

Talk with a New Mexico cannabis CPA

Bring your license types, current books and open deadlines. We will tell you what needs to happen first and in what order.